The Lancet  Neurology Autoimmune Disorder Conference

The Lancet Neurology Autoimmune Disorders Conference

March 26-27, 2015 | Barcelona, Spain

CONFERENCE CHAIRS

Elena Becker-Barroso
Editor, The Lancet Neurology



Josep Dalmau
University of Pennsylvania, USA and University of Barcelona, IDIBAPS, and ICREA, Spain

Francesc Graus
University of Barcelona and IDIBAPS, Spain

The first case series of patients with anti-NMDA receptor encephalitis, an autoimmune disorder of the brain, were reported in 2007. The NMDA receptor has a crucial role in synaptic function, and this novel disease is not only providing insights into the function of the receptor in humans, but also into understanding immunological mechanisms of brain disease.

With this event, The Lancet Neurology will have the opportunity to disseminate cutting-edge clinical and laboratory findings, and to facilitate an authoritative discussion of autoimmune targets in the CNS, such as the NMDA receptor, paving the way for future research into immunological and synaptic mechanisms of brain disease.

The event will have a translational focus, covering mechanisms of immunity in the CNS, clinical consequences of autoimmunity, and experimental models to study anti-NMDA receptor encephalitis and other neurological diseases.

We invite you to join us and to submit an abstract of a poster, for presentation alongside our invited oral programme.

We look forward to seeing you in Barcelona.


Elena Becker-Barroso, Editor, The Lancet Neurology
Josep Dalmau, University of Pennsylvania, USA and University of Barcelona, IDIBAPS, and ICREA, Spain
Francesc Graus, University of Barcelona and IDIBAPS, Spain

 

Organised by

The Lancet

Supporting Journal

The Lancet Neurology